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Hansen M, Kongsgaard M, Holm L, Skovgaard D, Magnusson SP,
Qvortrup K, Larsen JO, Aagaard P, Dahl M, Serup A, Frystyk J,
Flyvbjerg A, Langberg H, Kjaer M. Effect of estrogen on tendon collagen
synthesis, tendon structural characteristics, and biomechanical properties in
postmenopausal women. J Appl Physiol 106: 1385–1393, 2009. First pub-
lished October 16, 2009; doi:10.1152/japplphysiol.90935.2008.—The
knowledge about the effect of estradiol on tendon connective tissue is
limited. Therefore, we studied the influence of estradiol on tendon
synthesis, structure, and biomechanical properties in postmenopausal
women. Nonusers (control, n  10) or habitual users of oral estradiol
replacement therapy (ERT, n  10) were studied at rest and in response
to one-legged resistance exercise. Synthesis of tendon collagen was
determined by stable isotope incorporation [fractional synthesis rate
(FSR)] and microdialysis technique (NH2-terminal propeptide of type I
collagen synthesis). Tendon area and fibril characteristics were deter-
mined by MRI and transmission electron microscopy, whereas tendon
biomechanical properties were measured during isometric maximal vol-
untary contraction by ultrasound recording. Tendon FSR was markedly
higher in ERT users (P 0.001), whereas no group difference was seen
in tendon NH2-terminal propeptide of type I collagen synthesis (P 
0.32). In ERT users, positive correlations between serum estradiol (s-
estradiol) and tendon synthesis were observed, whereas change in tendon
synthesis from rest to exercise was negatively correlated to s-estradiol.
Tendon area, fibril density, fibril volume fraction, and fibril mean area did
not differ between groups. However, the percentage of medium-sized
fibrils was higher in ERT users (P  0.05), whereas the percentage of
large fibrils tended to be greater in control (P 0.10). A lower Young’s
modulus (GPa/%) was found in ERT users (P  0.05). In conclusion,
estradiol administration was associated with higher tendon FSR and a
higher relative number of smaller fibrils. Whereas this indicates stimu-
lated collagen turnover in the resting state, collagen responses to exercise
were negatively associated with s-estradiol. These results indicate a pivotal
role for estradiol in maintaining homeostasis of female connective tissue.
connective tissue; tendon fibrils; insulin-like growth factor-I; extra-
cellular matrix; bone
CROSS-SECTIONAL FINDINGS INDICATE that sex hormones influence
tendon biomechanical properties (36), extracellular matrix adapt-
ability in response to mechanical loading (11, 21, 36, 41, 59),
and the risk of sustaining soft tissue injuries (11, 24, 25).
Estrogen receptors have been localized in ligaments (32, 33),
and tendons express transcripts for estrogen receptors (23).
Nevertheless, the effect of estrogen on tendon and ligament
turnover is not clarified. Thus an inhibiting effect (34, 60), no
effect (51), and a stimulating effect (32) on collagen synthesis
and fibroblast proliferation in vitro have been observed in
anterior cruciate ligament (ACL) tissue samples. These con-
trasting findings are probably related to the variation between
animal species and the applied methods. This underlines the
importance of performing human in vivo studies to elucidate
the effect of estrogen on human collagen metabolism.
Collagen fibrils are the basic force-transmitting unit of
tendons and, therefore, influence the mechanical properties of
tendons (47). Case reports suggest that tendons with a higher
proportion of larger collagen fibrils have greater tensile
strength (38). Also, a positive relationship between fibril di-
ameter and tendon stiffness has been demonstrated (7). How-
ever, the precise contribution of fibrillar diameter and compo-
sition to the mechanical properties and strength of tendinous
tissue remains to be firmly established. The effect of estrogen
on tendon fibril characteristic is not known.
Type I collagen (CTX-I) is the main protein component in
bone and tendon tissue. Bone mass density (BMD) decreases
by age, especially after menopause, whereas tendon cross-
sectional area (CSA) is greater in postmenopausal women
compared with young women (35). In postmenopausal women,
estrogen replacement therapy (ERT) preserves bone mass (58),
and the presence of estrogen, estrogen receptors, and mechan-
ical loading has synergistic positive effects on bone mass (9,
55). The effect of combined ERT and physical training on
tendons is elusive. A smaller tendon diameter has been ob-
served in postmenopausal female golf players who used hor-
mone replacement therapy compared with controls (11). Fur-
thermore, an inhibition of CTX-I expression has been demon-
strated when estradiol and tensile loading of ACL fibroblasts
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were combined, despite the fact that both stimuli upregulated
the expression of CTX-I when applied separately (32). These
findings suggest a differential effect of estrogen in bone and
tendons and estrogen in combination with mechanical loading.
The effect may either be direct or an indirect effect of estrogen
on other growth factors and cytokines known to influence
collagen turnover, such as insulin-like growth factor-I (IGF-I)
(2, 6, 8, 43, 56).
The primary aim of the present study was to examine the
effect of an enhanced serum concentration of estradiol on
tendon collagen synthesis at rest and in response to exercise. In
addition, we investigated the effects of long-term use of ERT
on tendon CSA, fibril characteristics, and tendon biomechani-
cal properties. Finally, BMD and markers for bone turnover
were measured to study any differential effects of estrogen




A cross-sectional design was used to compare the influence of
high- vs. low-estradiol levels on tendon tissue by recruiting postmeno-
pausal women who were nonusers or users of ERT. The effect of
exercise on tendon collagen synthesis was measured 24 h after a
one-legged exercise. The contralateral leg represented tendon collagen
synthesis at rest.
Subjects
The participants were 20 healthy, postmenopausal women, who
were nonsmokers and absent of metabolic disorders and orthopedic
tendon injuries, as judged by history and routine medical examination.
The subjects gave informed consent to the protocol, which was
approved by the Ethics Committee of Copenhagen and Frederiksberg
municipalities (KF-01–032/04). Ten women were long-term users of
ERT [17.4  2.6 treatment years (mean  SD), range 6–30 yr]. The
subjects were daily supplemented with 2 mg oral 17-estradiol (n 
6 Oestradiol; n  2 Oestrofem; n  1 Femanest, or n  1 Pygynon).
All subjects had started the use of ERT following hysterectomy. In
addition to ERT, one subject was supplemented with Trisekvens,
which contains a further 1–2 mg of 17-estradiol each day besides
synthetic progestogens (1 mg norethisteronacetat) 10 out of 28 days in
a pill cycle. The latter subject was excluded from the analysis for
differences between groups. Additionally, we included 10 postmeno-
pausal women (control) who had not been menstruating for the last
7.2  1.4 yr (range 2–15 yr). One control subject had used ERT for
a maximum of 3 mo 7 yr ago. Otherwise, none of controls had used
ERT. However, six of the controls had used oral contraceptives before
the menopause. To make the difference in estrogens (endogenous
secreted and synthetic ethinyl estradiol) between groups as large as
possible during the period in which samples were obtained, women
who used ERT were tested in the hours after the last pill ingestion.
The two groups were otherwise comparable based on age, height,
weight, body mass index, and body composition quantified by dual-
energy X-ray absorptiometry (Table 1).
Screening
All participants visited the laboratory 1–3 wk before study start to
receive detailed information about the experiment, a health examina-
tion, and blood samples, including hemoglobin, serum (s)-ferritin,
s-transferrin, leucocytes, s-thyroid stimulating hormone, plasma (p)-
creatinin, p-cholesterol, p-C-reactive protein, p-aminostransferase, p-
aspartate aminotransferase, p-alkaline phosphatase, and p-albumin.
All results were within the normal range. Training status of the groups
was compared in three different ways. 1) Daily physical activity level
(PAL) determined by use of a validated questionnaire was assessed
(1) (Table 1). 2) Estimated maximal oxygen uptake (V˙ O2max) per
kilogram body weight was estimated by a 10-min two-step submaxi-
mal bike test (3). The workload was increased once after 6 min, and
the heart rate registered when it was stable. Two of the subjects in the
ERT group were not tested due to influenza the week before. 3) One-
legged five repetitions maximum (RM) was measured in a Techno-
gym leg extension R.O.M machine (for details, see Ref. 14). PAL and
dynamic muscle strength were not significant different between the
groups, whereas estimated V˙ O2max was significantly higher in control
vs. ERT users.
Experimental Protocol and Methods
At day 1, the subjects performed 10 sets of 10 repetitions of
one-legged knee extension at 10 RM. A new set was started every
third minute. Subject fasted overnight (12 h) and arrived at the
laboratory at 8 AM the following day. The subjects were instructed to
avoid strenuous physical activity for at least 2 days before and during
the experimental days. Tendon collagen synthesis was measured by
microdialysis technique and by infusion of a flooding dose of stable
isotope labeled amino acids followed by patellar tendon biopsies
bilaterally.
Microdialysis. Fluid collected from the interstitial fluid surrounding
the patellar tendon by using a microdialysis technique was analyzed
for a marker of CTX-I synthesis, the amino terminal propeptide of
CTX-I (PINP) (31). The remaining dialysate was used for analyses of
IGF-I and IGF-binding proteins (IGFBPs) (1–4). After previous
preparation of incision sites with local anesthetic (lidocaine 1%),
ethylene oxide sterilized catheters with high molecular mass cut-off
(3,000 kDa, membrane length 30 mm, inner diameter 0.50 mm) were
inserted under ultrasound guidance in the peritendinous spaces of
patellar tendons, as previously described (31). The inflow tube of the
microdialysis catheter was connected to a high-precision syringe
pump with infusion rate of 2 l/min. The catheters were perfused with
a Ringer-acetate solution mixed with a small amount of radioactive
labeled glucose (D-[3-3H]glucose in aqueous solution steri-pack, Per-
kin Elmer Life and Analytical Science, Boston, MA; Net 331A, lot no.
3559-801). The total amount of radioactivity that the patients received
was 0.001 mSv. For comparison, the normal radioactivity dose that
a person in Denmark receives yearly is 3 mSv. A sample vial was
placed at the end of the outflow tube, and, after 30-min perfusion of
the catheter, dialysate was collected in three 1-h periods and stored at
80°C until the analyses were performed. The relative recovery (RR)
Table 1. Subject characteristics
Control ERT Users
n 10 10
Age, yr 604 614
Weight, kg 644 649
Height, cm 1636 1625
BMI, kg/m2 24.42.4 24.33.2
Body fat, % 345 367
LBM, kg 434 405
Estimated V˙ O2max, l/min 2.20.4 1.80.4†
Estimated V˙ O2max, l  min1  kg1 346 27.46*
PAL 1.80.2 1.70.3
Estimated 5 RM 319 279
Values are mean  SD; n, no. of subjects. ERT, estrogen replacement
therapy; BMI, body mass index (weight height2); LBM, lean body mass;
estimated V˙ O2max, maximal oxygen uptake estimated by a submaximal bike
test; PAL, physical activity level (daily estimated energy expenditure/esti-
mated basal metabolic rate) (1, 44); RM, repetition maximum during one-
legged dynamic strength test (kg). *P  0.05 and †P  0.06: control vs. ERT
users.
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over the membrane was determined for each dialysate sample (49).
The dialysate (3 l) was pipetted into a counting vial in duplicates and
mixed with 3 ml scintillation fluid (Ultima Gold, Perkin Elmer,
Boston, MA), and the samples were counted in a -counter. The mean
relative recoveries for the microdialysis catheters did not differ be-
tween groups (means  SE; control 36  3%, ERT users: 49  4%,
P  0.16).
Tendon collagen fractional synthesis rate. Measurement of tendon
collagen fractional synthesis rate (FSR) was performed according to
previously applied approaches (5, 42). Briefly, a flooding dose of
proline (3.75 g total; 0.75 g labeled L-[1-13C]proline; 99 atoms%
[13C]proline, Cambridge Isotope Laboratories, Andover, MA), 3.0 g
unlabeled [12C]proline (AppliChem, Darmstadt, Germany), was dis-
solved in 0.9% NaCl using a sterile technique and intravenously
infused over 3 min. After flooding, blood samples were drawn at 10-
to 60-min intervals to determine the area under the [13C]proline
enrichment curve in plasma measured as tracer-to-tracee ratio. Two
hours after the isotope flood (24 h postexercise), tendon biopsies were
taken from the patella tendon (10 mg) of each leg after previously
preparing incision sites with local anesthetic (lidocaine 1%). Tendon
biopsies were obtained by using a 16-G Monopty biopsy instrument
(Bard, Covington, GA) under ultrasound guidance. Biopsies were
cleared of external adipose tissue and blood, frozen in liquid nitrogen,
and stored at 80°C for subsequent analysis.
PLASMA PROLINE ENRICHMENT. Plasma proline was prepared as
previously described and analyzed as its t-butyldimethylsilyl deriva-
tive by gas chromatography-mass spectrometry (Trace GC 2000
series, MS, Automass Multi, Thermo Quest Finnigan, Paris, France)
(4, 50) using a CP-SIL 8, CB low bleed, 30 m  0.32 mm, 0.25-m
column (Chromepack, Varian, Palo Alto, CA).
TENDON PREPARATION. Details regarding this procedure have been
given elsewhere (5, 42). Briefly, tendon (5–10 mg) biopsies were
homogenized in buffer (0.15 M NaCl, 0.1% Triton X-100, and 0.02 M
Tris HCl, 5 mM EDTA, pH 7.4) and hydrolyzed in 6 M HCl at 110°C
overnight. Then amino acids were extracted through disposable col-
umns using acidic cation exchange resin (Dowex AG-50W, Bio-Rad,
Sundbyberg, Sweden). The amino acids were derivatized as their
N-acetyl-n-propyl esters (40), and the enrichment of the proline peak
was determined by gas chromatograph combustion isotope ratio mass
spectrometry (Delta Plus XL, Thermo Finnigan, Bremen, Germany)
using a column CP-Sil 19 CB 60 m 	 0.32 mm, coating 0.25 m
(ChromPack).
CALCULATIONS. Plasma [13C]proline enrichment was assumed to
represent the enrichment of the true precursor pool, prolyl-tRNA (4).
Thus tendon collagen FSR (%/h) 
Et/Ep 	 1/t	 100%, where 
Et
is the change in enrichment of proline in the individual tendon
samples compared with the tendon sample with the lowest enrich-
ments in the whole group, Ep is the average enrichment of the
precursor (plasma [13C]proline) determined as the area under the
time-plasma enrichment curve (Fig. 1), and t is the time (h) of tracer
incorporation.
Transmission electron microscopy. In case of remaining tendon
tissue after FSR analysis, a small specimen was used for transmission
electron microscopy (TEM) (control specimen: n  9, and ERT
specimen: n  6). The biopsy specimens for TEM were fixed in a 2%
glutaraldehyde in 0.05 M sodium phosphate buffer (pH 7.2) and
stored at 4°C until subsequent analyses. The procedure for TEM and
the following measurements of collagen fibril diameter have previ-
ously been described in details (38).
STEREOLOGY. A simple, random sample of 10 digitized electron
microscopy images was obtained from each biopsy cross section (Fig. 2).
The stereological analyses of collagen fibrils were carried out on a
computer monitor onto which the digitized electron microscopy image
was merged with a graphic representation of the stereological test
systems (C.A.S.T.-grid software, The International Stereology Center
at Olympus). Each TEM image was examined with 16 uniformly
positioned points and 16 uniformly positioned unbiased counting
frames (19), each of area 0.0426 m2, in a fixed position relative to
the image. The counting frames covered 15% of the area of the TEM
images. On average, 175  13 fibrils (range 118–253) were analyzed
per biopsy cross section in the control specimens, and 189  11 from
each of the ERT specimens (range 157–235). All measurements were
performed in a blinded fashion.
Patellar tendon CSA and length. Patellar tendon CSA and length
were determined with magnetic resonance imaging (MRI) on the day
before the biopsy procedure, as previously described (29). Patellar
tendon CSA was measured 1) just distal to the patellar insertion;
2) just proximal to the tibia insertion; and 3) midway between the two
sites (29). The patellar tendon CSA and patellar tendon length were
manually outlined using the software program WEB 1000 (AGFA).
The mean value of three measurements of the same image was used
for analysis. The MRI assessment investigator was blinded with
regard to subject grouping. The average intraindividual coefficient of
variation (CV%) was 4%, whereas the interindividual CV% was 11%.
Tendon CSA was normalized to body mass to the power of 2/3 (39).
Patellar tendon mechanical properties. Measurements of patellar
tendon biomechanical properties were obtained on a separate day
before the experimental day. Details and reliability of this method
have been reported previously (22). Briefly, subjects were tested
following a 10-min warm-up on a stationary bike. Subjects performed
four to five ramped isometric maximal voluntary contractions over a
period of 10 s. A 2-min rest separated each ramp, and all measure-
ments were performed on both legs. Synchronized values of patellar
tendon elongation [change in length (
L)] (obtained from ultrasound
recordings) and patellar tendon forces [change in force (
F)] were
sampled during the ramp contractions. Tendon forces were calculated
by dividing measured knee extension moments by moment arms
estimated from individual femur lengths (57). Subsequently, all trials
were analyzed to a greatest common patellar tendon force for all
subjects (2,443 N) to take into account small differences in individual
peak knee extension moment. Force-deformation curves were fitted to
a second- or third-order polynomial fit that, in all cases, exceeded R2 
0.95. Tendon strain (





strain) were calculated in the final 20% of the
force-deformation and stress-strain curves, respectively (22). Analysis
was performed in an investigator-blinded fashion. The proximal part
of the tendon was used for the calculation of tendon stress. The
proximal tendon CSA was used as this region had the smallest CSA
and was, therefore, subjected to the highest stress values.
Blood, dialysate, and urine analysis. All blood samples were taken
from an antecubital vein. Estradiol was analyzed by chemiluminescent
competitive immunoassay (Immulite 2500) (NPU 1972, estradiol;
Diagnostic Product, Los Angeles, CA), while testosterone was ana-
lyzed by liquid chromatography-mass spectrometry using an atmo-
spheric pressure chemical ionization interface (CV% 15%)(21).
s-IGF-I and dialysate IGF-I were determined by time-resolved im-
munofluorometric assay after acid-ethanol extraction, as previously
described (17). All samples were measured in the same assay run
Fig. 1. Plasma enrichment of [13C]proline after flooding dose of [1-13C]pro-
line (tracer-to-tracee ratio).
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(intra-assay CV% 5%). s-IGFBP-1 was determined by an in-house
radioimmunoassay with modifications (30) (CV% within and between
assay averaged 5 and 16%, respectively). s-IGFBP-3 was measured
by commercially available immunoradiometric assay (BioSource Europe,
Nivelles, Belgium) (CV% within and between assay: 5 and 10%,
respectively). Tendon dialysates were analyzed for IGFBP-1 to -4 by
Western ligand blotting, as previously described (16). Serum was
analyzed for PINP for indirect quantification of collagen synthesis in
bone (s-PINP). Tendon dialysate was similarly analyzed for PINP for
indirect quantification of local synthesis of CTX-I in tendon. The
analysis for PINP was performed using a sandwich ELISA utilizing
purified 1-chain specific rabbit antibodies (donated by B. Teisner,
Department of Medical Microbiology, University of Southern Den-
mark, Odense, Denmark) (26). The within- (double determination)
and between-assay CVs were, on average, 2.2 and 4.9%, respectively.
Urine samples were analyzed for CTX-I, as a marker for degradation
of CTX-I in bone, by an enzyme immunosorbent assay (Urine Cross-
Laps ELISA, Nordic Bioscience Diagnostics a/s). Within- and be-
tween-assay CVs were 3.6  2.3 and 2.7  2.0%, respectively.
Urine-creatinine was analyzed by a two-point kinetic slide method,
with a Vitros 5.1 FS (670 nm).
Statistics and Data Analyses
Two-way repeated-measures ANOVA (one-factor repetition) was
used to test for difference between groups in tendon FSR and tendon
PINP and to elucidate if the response to exercise was influenced by the
administration of estrogen. If results showed P  0.05, post hoc
analyses were performed using pairwise multiple-comparison proce-
dures (Holm-Sidak method). Student’s unpaired t-tests were used to
test for differences between groups in the other parameters. For test of
differences in the distribution of fibrils between groups, the fibrils
were divided into three intervals: 60 nm, 60–90 nm, and 90 nm.
The intervals chosen were based on earlier published results (54). The
individual values for the biomechanical test parameters were analyzed
at the same individual common force and the same common force for
all of the subjects (29). Linear regression analyses between several of
the measured parameters were performed between the main parame-
ters [s-estradiol, tendon synthesis (PINP, FSR)]. The baseline char-
acteristics of the subject groups are presented as means  SD,
whereas the results are presented as means  SE. The level of
significance was set at P  0.05. The statistical analyses were
performed using the statistical software package Prism version 4.01
(GraphPad, San Diego, CA, 2004).
RESULTS
Sex Hormones
Estradiol was below the detection level in 8 of 10 controls
(10 nmol/l). In the remaining two controls, s-estradiol was
0.11 and 0.21 nmol/l, respectively. In contrast, s-estradiol was
above detection level in all women using ERT. Mean s-
estradiol in ERT users was 0.39  0.04 nmol/l (range 0.18–
0.60 nmol/l). Estradiol was 1.3 nmol/l in the woman using a
double dose. s-Testosterone was not significant different be-
tween groups (control: 0.87  0.10 nmol/l; ERT users: 0.72 
0.08 nmol/l, P  0.30).
Tendon Synthesis (Stable Isotope: FSR)
At rest, tendon collagen FSR was 47% higher in ERT users
compared with control (P  0.01) (Fig. 3). In the exercise leg
tendon collagen FSR was 86% higher in ERT users compared
with control (P  0.001). When analyzing data from the ERT
users, a positive association between s-estradiol and tendon
FSR was observed at rest (r2  0.41, P  0.06) and after
exercise (r2  0.80, P  0.001). Two-way repeated-measures
ANOVA showed that no effect of exercise (P  0.33) or
interaction between sex hormonal levels and exercise (P 
0.13) was observed in the 24-h post-exercise biopsy.
Tendon Synthesis (Microdialysis: PINP)
The marker for tendon collagen synthesis (PINP) was not
different between ERT users and control (P  0.32) (Fig. 3).
Neither was a significant response to exercise observed (P 
0.21, interaction P  0.59). In ERT users, s-estradiol was
positively correlated to tendon synthesis at rest (r2 0.47, P
0.05) (Fig. 3), and the subject receiving a double dose of
estradiol strengthened this association (r2  0.68, P  0.01)
(data not shown). When including the subject receiving a
double dose of estradiol, a negative correlation between
s-estradiol and the response to exercise was observed
(
PINP, r2  0.75, P  0.01).
Tendon Fibril Characteristics
Tendon fibril characteristics were analyzed in a subgroup of
subjects (control n  9, ERT users n  6). No significant
difference in fibril density (P  0.32), volume fraction (P 
0.26), or mean fibril size (P  0.53) was observed between the
two groups (Fig. 4). Nevertheless, in ERT users, a greater
percentage of the fibrils had a diameter within the interval of
60–90 nm compared with controls (P  0.05) (Fig. 4). In
contrast, controls had a greater percentage of large fibrils (90
nm in fibril diameter), although this difference only tended
significance (P  0.10). No significant group difference was
observed with regard to percentage of small-sized (0–30 nm in
fibril diameter) fibrils (P  0.32).
Fig. 2. Transmission electron microscopy of
collagen fibrils from patella tendon with
varying fibril diameter. Left: control sub-
jects. Right: estrogen replacement therapy
(ERT) user.
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ERT did not influence tendon CSA significantly at either the
distal (control 84 7 mm2; ERT users 87 4 mm2, P 0.41),
the mid- (control 82  7 mm2; ERT users 82  3 mm2, P 
0.98), or the proximal level (control 73  6 mm2; ERT users
80  4 mm2, P  0.77) of the patellar tendon. However,
compared with young, healthy women (24  3 yr), the prox-
imal part of the patellar tendon CSA was greater in elderly
ERT users, both in absolute values (P  0.01) and after
adjustment for weight (P  0.01) (Fig. 5). Similarly, tendon
CSA tended to be greater at the proximal level in elderly
controls compared with young (P  0.10). At the distal level
of the tendon, no significant difference related to age was
observed (Fig. 5).
Tendon Biomechanical Properties
The maximal isometric strength (peak moment) was not
significant different between groups (control 118  6 N m,
ERT users 108  9 N m, P  0.37). However, the calculated
maximal tendon force was higher in control compared with ERT
users (4,145  203 vs. 3,296  204 N, P  0.05) (Table 2).
Young’s modulus was significantly greater in controls com-
pared with ERT users (Table 2). No other differences in tendon
biomechanical properties were observed between groups (ten-
don stress P  0.16, strain P  0.91, stiffness P  0.55, and
peak moment P  0.24) (Table 2).
Fig. 3. Top left: patellar tendon collagen frac-
tional synthesis rates (FSR) at rest and 24 h after
exercise in postmenopausal women who used
ERT and postmenopausal women who did not use
ERT (control). **P  0.01 and **P  0.001,
unpaired t-test, control vs. ERT users. Top right:
relationship between tendon FSR and serum (s)-
estradiol in ERT users at rest (r2  0.41, P 
0.06) and postexercise (r2  0.80, P  0.001).
Bottom left: NH2-terminal propeptide of type I
collagen (PINP) as a marker for tendon synthesis.
Bottom right: relationship between tendon synthesis
(PINP) and s-estradiol in ERT users at rest (r2 
0.47, P  0.05) and postexercise (r2  0.52, P 
0.05). Values are means  SE.
Fig. 4. Absolute collagen fibril diameter distribution in patellar tendon biop-
sies from postmenopausal women who use ERT (n  6) and do not use ERT
(control) (n  9). The table shows data for fibril density (no. fibrils/m2),
mean fibril diameter (dia) (nm2), fibril volume (fibril area/total area), and the
relative (%) distribution within each groups of fibrils with a fibril diameter
within the intervals 60, 60–90 nm, and 90 nm. Values are means  SE.
*P  0.05 and (*)P  0.10, unpaired t-test, control vs. ERT users.
Fig. 5. Patellar tendon cross-sectional area (CSA) just distal to the patellar
insertion (proximal) and just proximal to the tibia insertion (distal) in post-
menopausal women who used ERT (ERT users) or did not use ERT (control),
and in young eumenorrheic women. Values are means  SE. **P  0.01 and
(*) P  0.10, unpaired t-test, control vs. ERT users.
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BMD and Markers for Bone Turnover
BMD was higher in ERT users than in control when calcu-
lated as the average for whole body (P  0.01), spine (P 
0.01), or legs (P  0.05). Pelvis BMD was not significantly
different between groups (P  0.13) (Table 3). s-PINP, a
marker for synthesis of CTX-I in bone, was lower in ERT users
compared with control (P  0.01). When s-estradiol in ERT
users was compared with the corresponding s-PINP, a ten-
dency toward a negative association was observed (r2  0.40,
P 0.07). The marker for bone degradation, urine-CTX-I, was
not significantly different between groups after adjustment for
urine concentration (P  0.19) (Table 3).
IGF-I and IGFBPs
IGF-I was significantly lower in ERT users than in control,
both in serum (P  0.05) and in the interstitial fluid surround-
ing the patellar tendon (P  0.01) (Table 4). In contrast, no
significant difference in IGFBPs in serum was observed (s-
IGFBP-1 P 0.15; IGFBP-3 P 0.14). Furthermore, IGFBPs
in the interstitial tendon fluid did not differ significantly be-
tween groups, although IGFBP-3 tended to be significant (P 
0.06) (Table 4).
DISCUSSION
The present study shows that ERT has a marked effect on
tendon collagen metabolism. A higher tendon FSR was ob-
served in ERT users compared with control. This might be
related to the differences in the fibril structural distribution and
the lower relative stiffness during maximal isometric voluntary
contraction seen in ERT users compared with control.
Tendon Synthesis
To our knowledge, the effect of ERT on tendon FSR has not
been measured before, but the present results are in concert
with observations showing a stimulating effect of estradiol on
the expression of CTX-I in porcine ACL (32) and in pelvic
connective tissue in human and rhesus macaques (10, 15). The
stimulating effect of estradiol on tendon collagen synthesis in
the resting state was further supported by a positive correlation
between s-estradiol and tendon collagen synthesis.
In contrast to tendon FSR, no significant difference between
groups was observed for tendon PINP. PINP is a marker for the
synthesis of newly synthesized soluble collagen molecules into
the pool of free collagen, which is not necessarily built into the
final tendon collagen structure, whereas tendon FSR corre-
sponds to the synthesis rate of both soluble, but probably
primarily insoluble, mature collagen. Therefore, the observed
differences between the isotope data and microdialysis data in
the present study may partly be explained by ERT especially
having a marked stimulating effect on the incorporation of
immature collagen molecules into the fibrils. The stimulating
effect of estradiol on tendon collagen synthesis (PINP) may be
counteracted by the indirect effect of ERT administration,
which may explain no difference between groups in tendon
PINP. Although speculative, such an explanation could be
supported by the fact that IGF-I was reduced in ERT users,
whereas IGFBPs were unchanged, which indicates a lower
IGF-I bioavailability, as observed by others (6, 8, 27). It is well
documented, at least in young animals, that IGF-I exerts
anabolic effects on tendon fibroblasts by increasing collagen
synthesis in a dose-dependent manner (2, 43, 45, 56). In
support of this, a lower tendon and muscle collagen FSR, and
at the same time a markedly lower bioavailability of IGF-I
within these tissues, have been observed in young oral contra-
ceptive users compared with control (21). Moreover, when
analyzing the synthesis data in ERT users separately, a positive
correlation between tendon FSR and tendon PINP was ob-
served (r2  0.43; P  0.05). This indicates that the differen-
tial effect of ERT on tendon synthesis when comparing the
groups by the two present methods is probably related to
indicted effects of ERT and is not only a methodological issue.
Table 2. Biomechanical tendon properties
Control ERT Users
n 9 8
Stress, MPa 373 301
Strain, % 5.40.5 5.30.3
Stiffness, N/mm 3,094248 2,821339
Young’s modulus, GPa/% 1.80.2 1.30.1*
Peak moment, N  m 1186 1088
Maximum force tendon, N 4,145203 3,296204*
Values are means  SE; n, no. of subjects. The values are calculated based
on the same common force (common force 2,443 N) to adjust for individual
differences in muscle strength. Description of the test parameters is given in
MATERIALS AND METHODS. *P  0.05: control vs. ERT users.
Table 3. BMD and markers for bone turnover in ERT users
and controls
Controls ERT Users P Value
n 10 9
Bone mass density
Total BMD, g/cm2 1.080.02 1.180.02 0.01
Spine BMD, g/cm2 0.960.03 1.160.05 0.01
Pelvis BMD, g/cm2 1.010.03 1.080.04 0.13
Leg BMD, g/cm2 1.130.06 1.220.03 0.05
Bone turnover markers
s-PINP, ng/ml 9810 565 0.05
Urine CTX-I, mg/mmol creatinine 21655 13614 0.19
Values are mean  SE; n, no. of subjects. Total BMD, mean whole body
bone mass density; s-PINP, serum concentrations of NH2-terminal propeptide
of type I collagen (marker for type I collagen synthesis); urine-CTX-I, urine
concentrations of c-terminal telopeptides of type I collagen (marker for type I
collagen degradation). P values: control vs. ERT users.
Table 4. IGF and IGFBP-1 to -4 in serum and tendon
dialysate
n Control ERT Users
Serum
IGF-I, g/l 10/9 13413 957†
IGFBP-1, g/l 10/9 587 709
IGFBP-3, g/l 10/9 3,56298 3,419106
Tendon dialysate
IGF-I, g/l 9/9 8.91.7 3.90.7*
IGFBP-1, AU/mm2 8/8 11731 13126
IGFBP-2, AU/mm2 8/8 25862 18724
IGFBP-3, AU/mm2 8/8 2,338667 1,092330‡
IGFBP-4, AU/mm2 8/8 14556 15353
Values are means  SE; n, no. of subjects for control/ERT users. IGF-I,
insulin-like growth factor I; IGFBP, IGF-binding protein; AU, arbitrary units
(pixel intensity). *P 0.01, †P 0.05, and ‡P 0.06: control vs. ERT users.
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Exercise did not result in any significant response of tendon
FSR in either group. This is supported by earlier findings,
which showed no difference in tendon FSR 24 or 72 h after an
acute bout of strenuous exercise in young women (21a, 41). A
type II error cannot be excluded, but the results do not
indicate a marked stimulating effect of exercise on tendon
synthesis (FSR) in postmenopausal women. In contrast,
tendon FSR has been observed to be enhanced above resting
values 6 h postexercise, followed by a peak 24-h postexer-
cise in men (42). Taken together with the present results,
this may indicate a sex-specific difference in the response to
exercise in tendon FSR.
In accordance with tendon FSR results, tendon PINP did not
change in response to exercise. However, when focusing on the
data from the ERT users only, a negative correlation was
observed between s-estradiol and the response to exercise in
tendon PINP, suggesting a negative interaction between estra-
diol and mechanical loading on CTX-I synthesis, as has been
previously shown in vitro in porcine ACL preparations (32). In
support of this, a negative correlation between s-estradiol and
the response to strenuous exercise has been observed in young
eumenorrheic women (r2  0.72, P 0.05) (41). Furthermore,
an increase in tendon PINP in response to exercise has been
observed in young, eumenorrheic women exposed to a low
concentration of estradiol, whereas high exposure to synthetic
estradiol by administration of oral contraceptives seemed to
counteract the stimulating effect of exercise on tendon synthe-
sis (21). Therefore, the response to exercise in tendon synthesis
(PINP) seems to be negatively influenced by the presence of a
high s-estradiol concentration (endogenous secreted and/or
exogenous administrated estradiol). In this study, tendon FSR
did not appear to be affected by exercise in postmenopausal
women (Fig. 3); therefore, it cannot be concluded whether a
small change in PINP postexercise would have had any impli-
cations for the force-transmitting collagen fibril units and tissue
biomechanical properties when adapting to an increased me-
chanical loading during repetitive physical trainings bouts.
Tendon CSA and Fibril Characteristics
Tendon CSA did not differ between control and ERT users,
even though tendon FSR was significantly higher in ERT users.
Differences in tendon FSR without any significant change in
tendon CSA have been observed before, when young users and
nonusers of oral contraceptives were compared (21). A type II
error may cause this, since the group sizes in both studies were
rather small. An alternative explanation for the similar tendon
CSA between groups could be that ERT also increases
tendon collagen breakdown. This possibility is supported by
findings in other types of collagen-rich tissues, where estrogen
administration was linked to indications of a higher tendon
collagen turnover and a more immature tendon structure (15,
26). Nevertheless, fibril characteristics showed no significant
differences in mean fibril area or density between the two
groups in the present study. However, interestingly, a more
detailed analysis of the fibril size distribution showed a signif-
icantly larger relative contribution of medium-sized fibrils in
ERT users (%total numbers of fibrils), whereas control tended
to have a larger relative contribution of larger fibrils (%total
numbers of fibrils). A larger fibril diameter in subjects charac-
terized by low estradiol exposure is in accordance with animal
findings (20).
Training and loading influence tendon size and biomechani-
cal properties (29, 37). V˙ O2max and maximal tendon force were
higher in control compared with ERT users, but no association
was observed between either the mean fibril area, fibril volume
fraction, or fibril density, when these parameters were pooled
for all subjects and correlated to either V˙ O2max, muscle
strength, or PAL. Similarly, body composition (weight, lean
body mass, body mass index) did not appear to be related to
fibril characteristics. This observation supports the idea that the
morphological difference between groups may be induced by
ERT administration.
Tendon proximal CSA was greater in postmenopausal
women compared with our laboratory’s earlier findings in
young women (21). This observation of an age-related increase
in tendon CSA is in line with cross-sectional data showing a
greater Achilles tendon CSA in postmenopausal women com-
pared with young women (35). Furthermore, in the present
study, 25% of the fibrils in the specimen from the patellar
tendon had a small diameter (between 0 and 60 nm). This is in
contrast to young subjects (27 yr, range 19–40 yr), in whom
73% of the fibrils had a diameter 60 nm (54). Taken
together, these findings suggest an altered balance between
collagen synthesis and breakdown with aging in women.
Biomechanical Properties
A lower relative tendon stiffness (Young’s modulus) was ob-
served in ERT users compared with controls. Based on the present
knowledge about the relation between tendon structure and bio-
mechanical properties (7, 37), this novel finding corresponds very
well with 1) the observed enhanced tendon synthesis in ERT
users, indicating a higher collagen turnover; 2) the fibril charac-
teristics showing a nonsignificant higher fibril density and a lower
mean fibril size; and 3) the relative higher numbers of smaller
fibrils in ERT users compared with controls. In addition, our
observations provide a further clarification of earlier findings,
revealing lower maximal load at tissue rupture in ACL from
ovariectomized rabbits, which had been exposed to high estrogen
levels for 1 mo compared with controls (52).
Bone Turnover and BMD
Bone collagen synthesis appears to increase during aging,
indicated by markers for bone formation (18). Nevertheless, new
findings suggest that the ability to process newly synthesized
collagen to fully cross-linked mature bone collagen structure
might be reduced in postmenopausal women (53). Taken together
with an enhanced bone resorption in postmenopausal women, this
may explain the well-known, age-dependent reduction in BMD
(as an indicator for a reduction in bone mass). In the present study,
use of ERT was associated with a lower concentration of a marker
for bone collagen (PINP) synthesis compared with controls. This
has been shown by others (58). The higher BMD in ERT users in
the present study might be explained by an increase in the
synthesis of mature bone collagen tissue, even though ERT seems
to reduce the synthesis of new collagen molecules (indicated by
lower s-PINP). An alternative explanation is that ERT reduces oste-
oclast activity and thereby bone collagen breakdown rate (12). How-
ever, the marker for bone collagen breakdown was not significantly
reduced in ERT users in the present study compared with control.
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The influence of ERT on collagen metabolism may differ
between collagen-rich tissues. Results indicate that tendon
collagen content is higher in elderly women compared with
young women (21). This is in contrast to the well-documented,
age-dependent decrease in bone mass. Furthermore, in the
present study, a positive association between s-estradiol and
tendon synthesis (peritendionous PINP) was observed, whereas
a tendency toward a negative association between s-estradiol
and the marker for bone collagen synthesis (s-PINP) was
observed. The mechanism behind this discrepancy between
tissues might be related to differences in type and distribution
of estrogen receptors and/or other growth factors important for
the signaling cascades in the two types of tissues.
Methodological Considerations
PINP was used as a marker of collagen synthesis in bone and
in tendons. PINP, as the NH2-terminal extension peptide, is
cleaved from procollagen by specific proteinases in a one-to-
one manner, which thereby enables the remaining collagen to
aggregate and form fibrils (28). As CTX-I mainly resides in
bone, s-PINP mainly reflects the synthesis of collagen in bone.
However, by placing microdialysis catheters in the peritendi-
nous space of the patella tendon, it is possible to measure local
PINP, assumed to primarily represent synthesis of collagen
within the patellar tendon tissue. This is supported by findings
showing marked changes in PINP in the peritendinous space of
the Achilles tendon and only minor changes in blood in
response to mechanical loading (31). Another source, which
could contribute to PINP in the dialysate, is the skin (dermis).
CTX-I is the predominant type of collagen in skin (13).
However, validation of the microdialysis technique demon-
strated that the observed change in CTX-I propeptides does not
originate from skin (46).
A drawback of microdialysis is that the exchange rate has to
be determined over the semipermeable membrane and needs
subsequent adjustment for the recovery value to calculate true
interstitial values. Radioactive labeled glucose (0.180 kDa)
was used as a marker for RR of PINP (35 kDa) and IGF-I (7.6
kDa), as no radioactive-labeled PINP was commercially avail-
able. The RR was high (42%, range 20–81%) and not signif-
icantly different between groups. When calculating interstitial
concentrations, it was assumed that the relative loss of tracer
over the membrane was similar to RR of the metabolite of
interest. We cannot exclude an underestimation of the exact
interstitial concentration of the metabolites, but the error in the
calculation can be expected to be the same between subject
groups and between the legs (rest and exercise leg).
Conclusion
ERT and thus elevation of estradiol levels seem to influence
tendon morphology and biomechanical properties in post-
menopausal women compared with women exposed to low-
estradiol concentration. In contrast to the inhibiting effect of
ERT on bone collagen synthesis, the present results showed a
markedly higher tendon FSR in ERT users, which was related
to the enhanced estradiol concentration in a dose-dependent
manner. This observation did not have any significant influence
on tendon size. However, it was linked to the presence of
smaller fibrils and a higher fibril density, which supports the
fact that ERT increases tendon collagen turnover. Moreover,
the relative stiffness during mechanical loading was lower in ERT
users, and this could be related to a relatively higher proportion of
immature cross links and thereby a potential reduced tendon
strength in women with higher levels of estradiol.
ACKNOWLEDGMENTS
We thank the subjects for time and devotion to the study. Additionally, we
thank Peter Butty, Karen Mathiassen, Merete Møller, Kirsten Nyborg, Ann-
Marie Sedstrom, and Ann Christina R. Reimann for technical assistance, and
Statens Serum Institute for analyzing serum samples for testosterone.
GRANTS
This work was supported by the Danish Rheumatism Association, the
Danish Research Council, the Danish Health Science Research Board, the
Lundbeck Foundation, and the HS Foundation.
REFERENCES
1. Aadahl M, Jorgensen T. Validation of a new self-report instrument for
measuring physical activity. Med Sci Sports Exerc 35: 1196–1202, 2003.
2. Abrahamsson SO, Lundborg G, Lohmander LS. Recombinant human
insulin-like growth factor-I stimulates in vitro matrix synthesis and cell
proliferation in rabbit flexor tendon. J Orthop Res 9: 495–502, 1991.
3. A˚strand PO, Rodahl K. Textbook of Work Physiology–Physiological
Bases of Exercise. New York: McGraw-Hill, 1986.
4. Babraj J, Cuthbertson DJ, Rickhuss P, Meier-Augenstein W, Smith
K, Bohe J, Wolfe RR, Gibson JN, Adams C, Rennie MJ. Sequential
extracts of human bone show differing collagen synthetic rates. Biochem
Soc Trans 30: 61–65, 2002.
5. Babraj JA, Cuthbertson DJ, Smith K, Langberg H, Miller BF, Krogs-
gaard MR, Kjaer M, Rennie MJ. Collagen synthesis in human muscu-
loskeletal tissues and skin. Am J Physiol Endocrinol Metab 289: E864–
E869, 2005.
6. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM,
Blackman MR. Effects of oral versus transdermal estrogen on the growth
hormone/insulin-like growth factor I axis in younger and older postmeno-
pausal women: a clinical research center study. J Clin Endocrinol Metab
81: 2848–2853, 1996.
7. Birch HL. Tendon matrix composition and turnover in relation to func-
tional requirements. Int J Exp Pathol 88: 241–248, 2007.
8. Campagnoli C, Biglia N, Altare F, Lanza MG, Lesca L, Cantamessa
C, Peris C, Fiorucci GC, Sismondi P. Differential effects of oral
conjugated estrogens and transdermal estradiol on insulin-like growth
factor 1, growth hormone and sex hormone binding globulin serum levels.
Gynecol Endocrinol 7: 251–258, 1993.
9. Chen JL, Yao W, Frost HM, Li CY, Setterberg RB, Jee WS. Bipedal
stance exercise enhances antiresorption effects of estrogen and counteracts
its inhibitory effect on bone formation in sham and ovariectomized rats.
Bone 29: 126–133, 2001.
10. Clark AL, Slayden OD, Hettrich K, Brenner RM. Estrogen increases
collagen I and III mRNA expression in the pelvic support tissues of the
rhesus macaque. Am J Obstet Gynecol 192: 1523–1529, 2005.
11. Cook JL, Bass SL, Black JE. Hormone therapy is associated with smaller
Achilles tendon diameter in active post-menopausal women. Scand J Med
Sci Sports 17: 128–132, 2007.
12. D’Amelio P, Grimaldi A, Di BS, Brianza SZ, Cristofaro MA, Tamone
C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G. Estrogen deficiency
increases osteoclastogenesis up-regulating T cells activity: a key mecha-
nism in osteoporosis. Bone 43: 92–100, 2008.
13. Epstein EH Jr, Munderloh NH. Human skin collagen. Presence of type I
and type III at all levels of the dermis. J Biol Chem 253: 1336–1337, 1978.
14. Esmarck B, Andersen JL, Olsen S, Richter EA, Mizuno M, Kjaer M.
Timing of postexercise protein intake is important for muscle hypertrophy
with resistance training in elderly humans. J Physiol 535: 301–311, 2001.
15. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson
G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue
at menopause are counteracted by estrogen. Maturitas 24: 197–204, 1996.
16. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W.
Transient increase in renal insulin-like growth factor binding proteins
during initial kidney hypertrophy in experimental diabetes in rats. Diabe-
tologia 35: 589–593, 1992.
1392 EFFECT OF ESTROGEN ON TENDON TISSUE
J Appl Physiol • VOL 106 • APRIL 2009 • www.jap.org






17. Frystyk J, Dinesen B, Ørskov H. Non-competitive time-resolved im-
munofluorometric assays for determination of human insulin-like growth
factor I and II. Growth Regul 5: 169–176, 1995.
18. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H,
Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD. Markers of
bone resorption predict hip fracture in elderly women: the EPIDOS
Prospective Study. J Bone Miner Res 11: 1531–1538, 1996.
19. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A,
Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A.
Some new, simple and efficient stereological methods and their use in
pathological research and diagnosis. APMIS 96: 379–394, 1988.
20. Hama H, Yamamuro T, Takeda T. Experimental studies on connective
tissue of the capsular ligament. Influences of aging and sex hormones.
Acta Orthop Scand 47: 473–479, 1976.
21. Hansen M, Koskinen S, Petersen SG, Dossing S, Frystyk J, Flyvbjerg
A, Westh E, Magnusson SP, Kjaer M, Langberg H. Ethinyl estradiol
administration in women suppresses synthesis of collagen in tendon in
response to exercise. J Physiol 586: 3005–3016, 2008.
21a.Hansen M, Miller BF, Holm L, Doessing S, Petersen SG, Skovgaard D,
Frystyk J, Flyvbjerg A, Koskinen S, Pingel J, Kjaer M, Langberg H.
Effect of administration of oral contraceptives in vivo on collagen syn-
thesis in tendon and muscle connective tissue in young women. J Appl
Physiol (October 9, 2008). doi:10.1152/japplphysiol.90933.2008.
22. Hansen P, Bojsen-Moller J, Aagaard P, Kjaer M, Magnusson SP.
Mechanical properties of the human patellar tendon, in vivo. Clin Biomech
(Bristol, Avon) 21: 54–58, 2006.
23. Hart DA, Archambault JM, Kydd A, Reno C, Frank CB, Herzog W.
Gender and neurogenic variables in tendon biology and repetitive motion
disorders. Clin Orthop Relat Res 351: 44–56, 1998.
24. Hewett TE, Myer GD, Ford KR. Anterior cruciate ligament injuries in
female athletes. 1. Mechanisms and risk factors. Am J Sports Med 34:
299–311, 2006.
25. Holmes GB, Lin J. Etiologic factors associated with symptomatic Achil-
les tendinopathy. Foot Ankle Int 27: 952–959, 2006.
26. Jackson S, James M, Abrams P. The effect of oestradiol on vaginal
collagen metabolism in postmenopausal women with genuine stress in-
continence. BJOG 109: 339–344, 2002.
27. Kelly JJ, Rajkovic IA, O’Sullivan AJ, Sernia C, Ho KK. Effects of
different oral oestrogen formulations on insulin-like growth factor-I,
growth hormone and growth hormone binding protein in post-menopausal
women. Clin Endocrinol (Oxf) 39: 561–567, 1993.
28. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal
muscle to mechanical loading. Physiol Rev 84: 649–698, 2004.
29. Kongsgaard M, Reitelseder S, Pedersen TG, Holm L, Aagaard P, Kjaer
M, Magnusson SP. Region specific patellar tendon hypertrophy in humans
following resistance training. Acta Physiol (Oxf) 191: 111–121, 2007.
30. Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW,
Flyvbjerg A. Free and total insulin-like growth factor (IGF)-I, -II, and
IGF binding protein-1, -2, and -3 serum levels in patients with active
thyroid eye disease. J Clin Endocrinol Metab 88: 132–135, 2003.
31. Langberg H, Skovgaard D, Petersen LJ, Bu¨low J, Kjaer M. Type I
collagen synthesis and degradation in peritendinous tissue after exercise
determined by microdialysis in humans. J Physiol 521: 299–306, 1999.
32. Lee CY, Liu X, Smith CL, Zhang X, Hsu HC, Wang DY, Luo ZP. The
combined regulation of estrogen and cyclic tension on fibroblast biosynthesis
derived from anterior cruciate ligament. Matrix Biol 23: 323–329, 2004.
33. Liu SH, al Shaikh R, Panossian V, Yang RS, Nelson SD, Soleiman N,
Finerman GA, Lane JM. Primary immunolocalization of estrogen and
progesterone target cells in the human anterior cruciate ligament. J Orthop
Res 14: 526–533, 1996.
34. Liu SH, Al Shaikh RA, Panossian V, Finerman GA, Lane JM.
Estrogen affects the cellular metabolism of the anterior cruciate ligament.
A potential explanation for female athletic injury. Am J Sports Med 25:
704–709, 1997.
35. Magnusson SP, Beyer N, Abrahamsen H, Aagaard P, Neergaard K,
Kjaer M. Increased cross-sectional area and reduced tensile stress of the
Achilles tendon in elderly compared with young women. J Gerontol A
Biol Sci Med Sci 58: 123–127, 2003.
36. Magnusson SP, Hansen M, Langberg H, Miller B, Haraldsson B,
Westh EK, Koskinen S, Aagaard P, Kjaer M. The adaptability of
tendon to loading differs in men and women. Int J Exp Pathol 88:
237–240, 2007.
37. Magnusson SP, Narici MV, Maganaris CN, Kjaer M. Human tendon
behaviour and adaptation, in vivo. J Physiol 586: 71–81, 2008.
38. Magnusson SP, Qvortrup K, Larsen JO, Rosager S, Hanson P,
Aagaard P, Krogsgaard M, Kjaer M. Collagen fibril size and crimp
morphology in ruptured and intact Achilles tendons. Matrix Biol 21:
369–377, 2002.
39. Markovic G, Jaric S. Movement performance and body size: the relationship
for different groups of tests. Eur J Appl Physiol 92: 139–149, 2004.
40. Meier-Augenstein W. Applied gas chromatography coupled to isotope
ratio mass spectrometry. J Chromatogr A 842: 351–371, 1999.
41. Miller BF, Hansen M, Olesen JL, Schwarz P, Babraj JA, Smith K,
Rennie MJ, Kjaer M. Tendon collagen synthesis at rest and after exercise
in women. J Appl Physiol 102: 541–546, 2006.
42. Miller BF, Olesen JL, Hansen M, Dossing S, Crameri RM, Welling RJ,
Langberg H, Flyvbjerg A, Kjaer M, Babraj JA, Smith K, Rennie MJ.
Coordinated collagen and muscle protein synthesis in human patella tendon
and quadriceps muscle after exercise. J Physiol 567: 1021–1033, 2005.
43. Murphy DJ, Nixon AJ. Biochemical and site-specific effects of insulin-
like growth factor I on intrinsic tenocyte activity in equine flexor tendons.
Am J Vet Res 58: 103–109, 1997.
44. Nordic Council of Ministers. The Nordic Nutrition Recommendations
(4th Ed.). Copenhagen: Norden, 2004.
45. Olesen JL, Heinemeier KM, Haddad F, Langberg H, Flyvbjerg A,
Kjaer M, Baldwin KM. Expression of insulin-like growth factor I,
insulin-like growth factor binding proteins, and collagen mRNA in me-
chanically loaded plantaris tendon. J Appl Physiol 101: 183–188, 2006.
46. Olesen JL, Langberg H, Heinemeier KM, Flyvbjerg A, Kjaer M.
Determination of markers for collagen type I turnover in peritendinous
human tissue by microdialysis: effect of catheter types and insertion
trauma. Scand J Rheumatol 35: 312–317, 2006.
47. Provenzano PP, Vanderby R Jr. Collagen fibril morphology and orga-
nization: implications for force transmission in ligament and tendon.
Matrix Biol 25: 71–84, 2006.
48. Rennie MJ, Edwards RH, Halliday D, Matthews DE, Wolman SL,
Millward DJ. Muscle protein synthesis measured by stable isotope
techniques in man: the effects of feeding and fasting. Clin Sci (Lond) 63:
519–523, 1982.
49. Scheller D, Kolb J. The internal reference technique in microdialysis: a
practical approach to monitoring dialysis efficiency and to calculating tissue
concentration from dialysate samples. J Neurosci Methods 40: 31–38, 1991.
50. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW. Use of
t-butyldimethylsilylation in the gas chromatographic/mass spectrometric
analysis of physiologic compounds found in plasma using electron-impact
ionization. Anal Biochem 141: 101–109, 1984.
51. Seneviratne A, Attia E, Williams RJ, Rodeo SA, Hannafin JA. The effect
of estrogen on ovine anterior cruciate ligament fibroblasts: cell proliferation
and collagen synthesis. Am J Sports Med 32: 1613–1618, 2004.
52. Slauterbeck J, Clevenger C, Lundberg W, Burchfield DM. Estrogen
level alters the failure load of the rabbit anterior cruciate ligament.
J Orthop Res 17: 405–408, 1999.
53. Smith K, Rennie MJ. New approaches and recent results concerning human-
tissue collagen synthesis. Curr Opin Clin Nutr Metab Care 10: 582–590, 2007.
54. Svensson M, Movin T, Rostgard-Christensen L, Blomen E, Hultenby K,
Kartus J. Ultrastructural collagen fibril alterations in the patellar tendon 6
years after harvesting its central third. Am J Sports Med 35: 301–306, 2007.
55. Tobias JH. At the crossroads of skeletal responses to estrogen and
exercise. Trends Endocrinol Metab 14: 441–443, 2003.
56. Tsuzaki M, Brigman BE, Yamamoto J, Lawrence WT, Simmons JG,
Mohapatra NK, Lund PK, Van WJ, Hannafin JA, Bhargava MM,
Banes AJ. Insulin-like growth factor-I is expressed by avian flexor tendon
cells. J Orthop Res 18: 546–556, 2000.
57. Visser JJ, Hoogkamer JE, Bobbert MF, Huijing PA. Length and
moment arm of human leg muscles as a function of knee and hip-joint
angles. Eur J Appl Physiol Occup Physiol 61: 453–460, 1990.
58. Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N,
Robinson V, Henry D, O’Connell D, Cranney A. Meta-analyses of
therapies for postmenopausal osteoporosis. V. Meta-analysis of the effi-
cacy of hormone replacement therapy in treating and preventing osteopo-
rosis in postmenopausal women. Endocr Rev 23: 529–539, 2002.
59. Westh E, Kongsgaard M, Bojsen-Moller J, Aagaard P, Hansen M,
Kjaer M, Magnusson SP. Effect of habitual exercise on the structural and
mechanical properties of human tendon, in vivo, in men and women.
Scand J Med Sci Sports 18: 23–30, 2008.
60. Yu WD, Panossian V, Hatch JD, Liu SH, Finerman GA. Combined
effects of estrogen and progesterone on the anterior cruciate ligament. Clin
Orthop 383: 268–281, 2001.
1393EFFECT OF ESTROGEN ON TENDON TISSUE
J Appl Physiol • VOL 106 • APRIL 2009 • www.jap.org
 by 10.220.33.3 on January 14, 2017
http://jap.physiology.org/
D
ow
nloaded from
 
